[免疫检查点抑制剂治疗的副作用:重症监护专家需要知道什么]
Nina Buchtele1,2,3, Hanna Knaus4, Peter Schellongowski5,6
1Intensivstation 13i2, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Wien, Österreich. nina.buchtele@meduniwien.ac.at.
检查点抑制剂彻底改变了癌症治疗,但可能导致与免疫相关的不良事件 (irAEs). 早期识别和管理,包括皮质类固醇,对于潜在的可逆器官衰竭至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 关键护理医学 关键护理医学
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
06:07Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
相关概念视频
Tumor Immunotherapy
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease II: Clinical Manifestations
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
